Skip to content

Combined Atropine with Orthokeratology in Chinese Childhood Myopia Control -A Randomized, Controlled, Double-blind and Multi-center Trial

Combined Atropine with Orthokeratology in Chinese Childhood Myopia Control -A Randomized, Controlled, Double-blind and Multi-center Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800018419
Enrollment
Unknown
Registered
2018-09-17
Start date
2018-10-01
Completion date
Unknown
Last updated
2023-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopia

Interventions

control group:combined Orthokeratology with placebo eye drops
experimental group:Combined 0.01% Atropine With Orthokeratology

Sponsors

Shanghai General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
8 Years to 12 Years

Inclusion criteria

Inclusion criteria: 1. Aged 8 to 12 years; 2. Cycloplegic spherical equivalent refractive error (SER) of -1.00 to -4.00D, astigmatism of <= 1.50D; 3. Best-corrected visual acuity 1.0 or better in both eyes; 4. The refraction increased not less than 0.50D in the past one year; 5. The birth weight more than 1500g; 6. Agree to the randomized and to attend the scheduled visits and aftercare.

Exclusion criteria

Exclusion criteria: 1. Children with ocular disorders such as strabismus and amblyopia; 2. History of myopia control treatment (e.g. soft contact lenses, progressive add spectacles, orthokeratology, atropine eye drops); 3. A history of allergy to atropine; 4. Ocular and systemic conditions which might affect orthokeratology wear (for example, cataract, ptosis); 5. Poor compliance with schedule visits.

Design outcomes

Primary

MeasureTime frame
axial length;

Countries

China

Contacts

Public ContactBilian Ke

Shanghai General Hospital

kebilian@126.com+86 13386259873

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 20, 2026